On April 1, 2022, The Hospital for Sick Children (SickKids) and CHEO marked the completion of the first year of a two-year mandate of Genome-wide Sequencing Ontario: a pilot implementation for rare disease diagnostics (GSO). You can learn more about GSO’s progress through its first year and its impact on [...]
Beginning April 1st, 2022, trio cases (proband + two parents) will be randomized to receive either exome sequencing or whole genome sequencing. Singleton, Duo, Quad, and Trio cases that do not include both parents will continue to receive exome sequencing. The genetic test report will include information on the type [...]
LifeLabs will collect samples for genome-wide sequencing performed through GSO under the Ministry of Health's Community Access Pilot for Laboratory Services. A communication was sent to all LifeLabs collection sites on January 18th 2022 to notify each site of the change.